Information Provided By:
Fly News Breaks for August 13, 2015
ENZY
Aug 13, 2015 | 07:10 EDT
Wells Fargo analyst John Baumgartner upgraded Enzymotec to Outperform citing higher confidence in business stabilization and opportunities for growth following the company's Q2 results. Baumgartner raised his price target range for shares to $17-$18 from $9-$10.
News For ENZY From the Last 2 Days
There are no results for your query ENZY